University of Oxford pauses pediatric trial of its vaccine with AstraZeneca, pending review by UK regulator

A pediatric trial of the Oxford-AstraZeneca vaccine has been paused pending a review by the UK's medicines regulator of rare blood clot cases in adults, a University of Oxford spokesperson told CNN Tuesday.

The head of MHRA, Dr. June Raine, told CNN on Tuesday that the MHRA was"aware of the decision taken by the University of Oxford to pause dosing in the trial...whilst the MHRA safety review is ongoing." Regulators in other countries have also reported blood clots among people who have received the vaccine, particularly in Europe, where the AstraZeneca vaccine is widely used. Some countries are choosing to suspend the vaccine altogether, while others have limited its use to certain age groups.

Education Education Latest News, Education Education Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Oxford studying people deliberately reinfected with COVID-19 virusThe University of Oxford said on Monday it has launched a trial in which people who have already had Covid-19 are deliberately reinfected.
Source: inquirerdotnet - 🏆 3. / 86 Read more »